Hamieh, Nadine
Descatha, Alexis
Zins, Marie
Goldberg, Marcel
Czernichow, Sébastien
Hoertel, Nicolas
Plessz, Marie
Roquelaure, Yves
Limosin, Frédéric
Lemogne, Cédric
Matta, Joane
Airagnes, Guillaume
Funding for this research was provided by:
Direction de la Recherche, des Études, de l’Évaluation et des Statistiques
Article History
Received: 28 July 2021
Accepted: 21 December 2021
First Online: 13 January 2022
Competing interests
: Guillaume Airagnes declares personal fees from Pierre Fabre, Lundbeck and Pfizer, outside the submitted work. Cédric Lemogne declares personal fees from Boehringer Ingelheim, Janssen-Cilag, Lundbeck and Otsuka Pharmaceutical, outside the submitted work. Alexis Descatha declares personal fees from his mentioned affiliations, Elsevier Masson, outside the submitted work. Sebastien Czernichow declares honoraria from Novo Nordisk, Lilly France, Janssen‐Cilag, Fresenius Kabi in the last 36 months and he owns share of the company MyGoodLife, outside the submitted work. The other authors declare no competing interests.